Recombinant Human Erythropoietin Utilization in Department of Veterans Affairs Dialysis Units

American Journal of Kidney Diseases - Tập 24 - Trang 184-191 - 1994
Marsha Wolfson1, Diane J. Mundt1, Gerald G. Hawley1
1From The National Center for Cost Containment, Department of Veterans Affairs, Milwaukee, WI.

Tài liệu tham khảo

Mohini, 1989, Clinical efficacy of recombinant human erythropoietin in hemodialysis patients, Semin Nephrol, 9, 1621 Eschbach, 1989, Recombinant human erythropoietin in anemic patients with end-stage renal disease, Results of a phase III multicenter trial. Ann Intern Med, 111, 992 Carbide, 1993, Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis, Kidney Int, 43, S-11 Greer, 1992, Erythropoietin use by dialysis modality, J Am Soc Nephrol, 3, 425 Besarab, 1992, Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: The case for subcutaneous administration, J Am Soc Nephrol, 2, 1405, 10.1681/ASN.V291405 Kampf, 1992, Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administration, Nephron, 61, 393, 10.1159/000186955 Lim, 1989, The safety and efficiency of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency, Am J Kidney Dis, 14, 496, 10.1016/S0272-6386(89)80150-7 Granolleras, 1991, Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: A randomized, double-blind crossover study, Clin Nephrol, 36, 294 US Renal Data System, USRDS 1991 Annual Data Report: Bethesda, MD, The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 1991 Van Wyck, 1989, Iron deficiency in patients with dialysisassociated anemia during erythropoietin replacement therapy: Strategies for assessment and management, Semin Nephrol, 9, 21 Van Wyck, 1989, Iron status in patients receiving erythropoietin for dialysis-associated anemia, Kidney Int, 35, 712, 10.1038/ki.1989.43 Watson, 1989, Adverse effects of therapy for the correction of the anemia in hemodialysis patients, Semin Nephrol, 9, 30 Shahidi, 1973, Androgens and erythropoiesis, N Engl J Med, 289, 72, 10.1056/NEJM197307122890205 Neff, 1981, A comparison of androgens for anemia in patients on hemodialysis, N Engl J Med, 304, 871, 10.1056/NEJM198104093041504 Hendler, 1974, Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis, N Engl J Med, 291, 1046, 10.1056/NEJM197411142912002 Ballal, 1991, Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease, Am J Kidney Dis, 17, 29, 10.1016/S0272-6386(12)80246-0 Lipschitz, 1984, Effect of age on hematopoiesis in man, Blood, 63, 502, 10.1182/blood.V63.3.502.502 Udupa, 1984, Erythropoiesis in the aged mouse: I. Response to stimulation in vivo, J Lab Clin Med, 103, 574 Shank, 1992, Recombinant hematopoietic growth factors: Comparative hematopoietic response in younger and older subjects, J Am Geriatr Soc, 40, 151, 10.1111/j.1532-5415.1992.tb01936.x